Daewoong Pharma (069620) — Net Asset Quality Index
Daewoong Pharma (069620) has a Net Asset Quality Index of 44.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩2.26 Trillion minus total liabilities of ₩1.26 Trillion yields net assets of ₩1.00 Trillion. A higher index indicates a stronger, lower-leverage balance sheet. See 069620 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Daewoong Pharma Net Asset Quality Index Over Time (2007–2024)
This chart shows how Daewoong Pharma's Net Asset Quality Index has evolved across 16 annual periods from 2007 to 2024. As of September 2025, the index stands at 44.4%, representing net assets of ₩1.00 Trillion against total assets of ₩2.26 Trillion KRW. Explore 069620 cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Daewoong Pharma (2007–2024)
The table below presents the year-by-year Net Asset Quality Index for Daewoong Pharma from 2007 to 2024, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 069620 stock market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 46.9% | ₩926.98 Billion | ₩1.98 Trillion | ₩1.05 Trillion | ▼ -4.4 pp |
| 2023 | 51.3% | ₩802.97 Billion | ₩1.57 Trillion | ₩762.77 Billion | ▲ +3.9 pp |
| 2022 | 47.4% | ₩741.22 Billion | ₩1.56 Trillion | ₩822.12 Billion | ▼ -2.2 pp |
| 2021 | 49.6% | ₩702.41 Billion | ₩1.42 Trillion | ₩712.77 Billion | ▼ -1.2 pp |
| 2020 | 50.9% | ₩695.25 Billion | ₩1.37 Trillion | ₩671.66 Billion | ▼ -0.2 pp |
| 2019 | 51.1% | ₩635.92 Billion | ₩1.25 Trillion | ₩609.75 Billion | ▲ +0.7 pp |
| 2018 | 50.3% | ₩607.81 Billion | ₩1.21 Trillion | ₩600.04 Billion | ▼ -1.7 pp |
| 2017 | 52.0% | ₩631.54 Billion | ₩1.21 Trillion | ₩581.99 Billion | ▼ -0.8 pp |
| 2016 | 52.8% | ₩604.55 Billion | ₩1.14 Trillion | ₩540.15 Billion | ▼ -8.6 pp |
| 2015 | 61.4% | ₩580.24 Billion | ₩944.53 Billion | ₩364.29 Billion | ▼ -4.2 pp |
| 2014 | 65.6% | ₩455.51 Billion | ₩694.26 Billion | ₩238.76 Billion | ▼ -10.0 pp |
| 2013 | 75.6% | ₩437.96 Billion | ₩579.01 Billion | ₩141.05 Billion | ▼ -4.5 pp |
| 2012 | 80.1% | ₩386.59 Billion | ₩482.34 Billion | ₩95.76 Billion | ▲ +7.4 pp |
| 2011 | 72.7% | ₩362.42 Billion | ₩498.46 Billion | ₩136.04 Billion | ▲ +15.4 pp |
| 2008 | 57.3% | ₩278.85 Billion | ₩486.24 Billion | ₩207.39 Billion | ▼ -11.3 pp |
| 2007 | 68.6% | ₩269.57 Billion | ₩392.81 Billion | ₩123.24 Billion | — |